GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaNutra SpA (FRA:761) » Definitions » YoY EBITDA Growth

PharmaNutra SpA (FRA:761) YoY EBITDA Growth : -0.77% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is PharmaNutra SpA YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PharmaNutra SpA's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -0.77%.

PharmaNutra SpA's EBITDA per Share for the three months ended in Mar. 2025 was €0.52.


PharmaNutra SpA YoY EBITDA Growth Historical Data

The historical data trend for PharmaNutra SpA's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaNutra SpA YoY EBITDA Growth Chart

PharmaNutra SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.62 26.64 24.26 11.27 18.11

PharmaNutra SpA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.00 50.64 49.34 6.63 -0.77

PharmaNutra SpA YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PharmaNutra SpA's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(3.346-2.833)/ | 2.833 |
=18.11 %

PharmaNutra SpA's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(0.518-0.522)/ | 0.522 |
=-0.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaNutra SpA YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PharmaNutra SpA's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaNutra SpA Business Description

Traded in Other Exchanges
Address
Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, Asia and others.

PharmaNutra SpA Headlines

No Headlines